title: Interpleural analgesia with bupivacaine following thoracotomy: ineffective results of a controlled study and pharmacokinetics.
abstract: OBJECTIVE
  To evaluate intrapleural analgesia with bupivacaine following partial pulmonary resection and to determine pharmacokinetic parameters of bupivacaine with epinephrine.
  
  
  METHODS
  Prospective, randomized study.
  
  
  METHODS
  Thoracic surgical clinic of a university-affiliated general hospital.
  
  
  METHODS
  Eighteen consecutive patients (13 men, 5 women) scheduled for pulmonary surgery by posterolateral thoracotomy.
  
  
  METHODS
  Bupivacaine was administered through an intrapleural catheter as a bolus dose of either 40 ml of 0.25% bupivacaine with epinephrine (0.5 mg per 100 ml of solution) (n = 10) or 20 ml of 0.5% bupivacaine with epinephrine (0.5 mg per 100 ml of solution) (n = 8) up to three times daily for a maximum time of 4 days.
  
  
  RESULTS
  Subjective evaluation of pain was performed using the visual analog scale (VAS) before and after each injection by response to spontaneous pain, coughing, deep breathing, and incision palpation. Maximum peak concentration (C Max) and maximum time to reach the peak concentration (T Max) were assessed after the first and last injections. Although VAS pain score decreased significantly, pain relief was not sufficient. C Max and T Max after the first and last injections were not significantly different between the two groups. In each group, C Max after the last injection was significantly higher than after the first injection.
  
  
  CONCLUSIONS
  Intrapleural analgesia conducted with 40 ml of 0.25% bupivacaine with epinephrine or 20 ml of 0.5% bupivacaine with epinephrine was insufficient for pain, despite high plasma bupivacaine concentration.
authors: Department of Anesthesiology, Hôpital Beaujon, Clichy, France.
authors: A
authors: A
authors: Elman
authors: B
authors: B
authors: Debaene
authors: C
authors: C
authors: Magny-Metrot
authors: G
authors: G
authors: Murciano
mesh_terms: D000082:Acetaminophen / Q000627:therapeutic use; D000698:Analgesia / Q000379:methods*; D001794:Blood Pressure / Q000502:physiology; D002045:Bupivacaine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002404:Catheterization / Q000295:instrumentation; D003371:Cough / Q000503:physiopathology; D011431:Dextropropoxyphene / Q000627:therapeutic use; D004837:Epinephrine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010149:Postoperative Pain / Q000517:prevention & control*; D010173:Palpation; D010994:Pleura; D011013:Pneumonectomy / Q000009:adverse effects; D011446:Prospective Studies; D012119:Respiration / Q000502:physiology; D013908:Thoracotomy / Q000009:adverse effects; D014797:Vital Capacity / Q000187:drug effects
chemical_list: D000082:Acetaminophen; D011431:Dextropropoxyphene; D002045:Bupivacaine; D004837:Epinephrine